Urolithiasis Management Devices Market Report

Urolithiasis Management Devices Market Analysis By Treatment Type (Extracorporeal Shock Wave Lithotripsy (Eswl), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatments (Watchful Waiting, Parathyroid Gland Surgery)), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers), And Segment Forecasts To 2024

  • Report ID: GVR-1-68038-152-8
  • Number of Pages: 115
  • Format: Electronic (PDF)

Table of Content

Chapter 1 Methodology & Scope
                    1.1 Research Methodology
                    1.2 Research Scope & Assumptions
                    1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Market Summary
Chapter 4 Market Variables, Trends& Scope
                    4.1 Market Segmentation & Scope
                        4.1.1 Market Driver Analysis
                        4.1.2 Market Restraint Analysis
                    4.2 Penetration & Growth Prospect Mapping
                    4.3 Urolithiasis Management Devices Market - SWOT Analysis, By Factor (political & legal, economic and technological)
                    4.4 Industry Analysis - Porter’s
Chapter 5 Market Categorization 1: Treatment Type Estimates & Trend Analysis
                    5.1 Urolithiasis Management Devices market: Treatment Type movement analysis
                    5.2 Extracorporeal Shock Wave Lithotripsy (ESWL)
                        5.2.1 Extracorporeal shock wave lithotripsy (ESWL) market, 2013 - 2024 (USD Million)
                    5.3 Intracorporeal Lithotripsy
                        5.3.1 Intracorporeal lithotripsy market, 2013 - 2024 (USD Million)
                    5.4 Percutaneous Nephrolithotomy
                        5.4.1 Percutaneous nephrolithotomy market, 2013 - 2024 (USD Million)
                    5.5 Other Treatments
                        5.5.1 Other treatments market, 2013 - 2024 (USD Million)
Chapter 6 Market Categorization 2: End-Use Estimates & Trend Analysis
                    6.1 Urolithiasis Management Devices market: End-Use movement analysis
                    6.2 Hospitals & Clinics
                        6.2.1 Hospitals & Clinics market, 2013 - 2024 (USD Million)
                    6.3 Ambulatory Surgical Centers
                        6.3.1 Ambulatory Surgical Centers market, 2013 - 2024 (USD Million)
Chapter 7 Market Categorization 3: Regional Estimates & Trend Analysis, by Treatment Type, and End-Use
                    7.1 Urolithiasis Management Devices market share by region, 2013 & 2024
                    7.2 North America
                        7.2.1 U.S.
                        7.2.2 Canada
                    7.3 Europe
                        7.3.1 UK
                        7.3.2 Germany
                    7.4 Asia Pacific
                        7.4.1 Japan
                        7.4.2 China
                        7.4.3 India
                    7.5 Latin America
                        7.5.1 Mexico
                        7.5.2 Brazil
                    7.6 MEA
                        7.6.1 South Africa
Chapter 8 Competitive Landscape
                    8.1 Strategy framework
                    8.2 Company Profiles
                        8.2.1 Allengers Medical Systems Ltd.
                             8.2.1.1 Company Overview
                             8.2.1.2 Financial Performance
                             8.2.1.3 Product Benchmarking
                             8.2.1.4 Strategic Initiatives
                        8.2.2 Boston Scientific Corporation
                             8.2.2.1 Company Overview
                             8.2.2.2 Financial Performance
                             8.2.2.3 Product Benchmarking
                             8.2.2.4 Strategic Initiatives
                        8.2.3 C.R. Bard, Inc.
                             8.2.3.1 Company Overview
                             8.2.3.2 Financial Performance
                             8.2.3.3 Product Benchmarking
                             8.2.3.4 Strategic Initiatives
                        8.2.4 Cook Medical
                             8.2.4.1 Company Overview
                             8.2.4.2 Financial Performance
                             8.2.4.3 Product Benchmarking
                             8.2.4.4 Strategic Initiatives
                        8.2.5 ConMed Corporation
                             8.2.5.1 Company Overview
                             8.2.5.2 Financial Performance
                             8.2.5.3 Product Benchmarking
                             8.2.5.4 Strategic Initiatives
                        8.2.6 DirexGroup
                             8.2.6.1 Company Overview
                             8.2.6.2 Financial Performance
                             8.2.6.3 Product Benchmarking
                             8.2.6.4 Strategic Initiatives
                        8.2.7 Dornier MedTech GmbH
                             8.2.7.1 Company Overview
                             8.2.7.2 Financial Performance
                             8.2.7.3 Product Benchmarking
                             8.2.7.4 Strategic Initiatives
                        8.2.8 Guangzhou Potent Optotronic Technology Co., Ltd.
                             8.2.8.1 Company Overview
                             8.2.8.2 Financial Performance
                             8.2.8.3 Product Benchmarking
                             8.2.8.4 Strategic Initiatives
                        8.2.9 HealthTronics, Inc.
                             8.2.9.1 Company Overview
                             8.2.9.2 Financial Performance
                             8.2.9.3 Product Benchmarking
                             8.2.9.4 Strategic Initiatives
                        8.2.10 Karl Storz GmbH & Co. KG
                             8.2.10.1 Company Overview
                             8.2.10.2 Financial Performance
                             8.2.10.3 Product Benchmarking
                             8.2.10.4 Strategic Initiatives
                        8.2.11 Lumenis
                             8.2.11.1 Company Overview
                             8.2.11.2 Financial Performance
                             8.2.11.3 Product Benchmarking
                             8.2.11.4 Strategic Initiatives
                        8.2.12 Olympus Corporation
                             8.2.12.1 Company Overview
                             8.2.12.2 Financial Performance
                             8.2.12.3 Product Benchmarking
                             8.2.12.4 Strategic Initiatives
                        8.2.13 Richard Wolf
                             8.2.13.1 Company Overview
                             8.2.13.2 Financial Performance
                             8.2.13.3 Product Benchmarking
                             8.2.13.4 Strategic Initiatives
                        8.2.14 Siemens Healthcare
                             8.2.14.1 Company Overview
                             8.2.14.2 Financial Performance
                             8.2.14.3 Product Benchmarking
                             8.2.14.4 Strategic Initiatives


List of Tables

TABLE 1 Country share estimation
TABLE 2 North America urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 3 North America urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 4 U.S. urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 5 U.S. urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 6 Canada urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 7 Canada urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 8 Europe urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 9 Europe urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 10 UK urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 11 UK urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 12 Germany urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 13 Germany urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 14 Asia Pacific urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 15 Asia Pacific urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 16 Japan urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 17 Japan urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 18 China urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 19 China urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 20 India urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 21 India urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 22 Latin America urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 23 Latin America urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 24 Mexico urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 25 Mexico urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 26 Brazil urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 27 Brazil urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 28 MEA urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 29 MEA urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 30 South Africa urolithiasis management devices market, by treatment type, 2013 - 2024 (USD Million)
TABLE 31 South Africa urolithiasis management devices market, by end-use, 2013 - 2024 (USD Million)


List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Urolithiasis management devices : Market Segmentation
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Urolithiasis management devices Porter’s analysis
FIG. 9 Urolithiasis management devices market treatment type outlook key takeaways
FIG. 10 Urolithiasis management devices market: treatment type movement analysis
FIG. 11 Global Extracorporeal Shock Wave Lithotripsy (ESWL) market, 2013 - 2024 (USD Million)
FIG. 12 Global Intracorporeal lithotripsy market, 2013 - 2024 (USD Million)
FIG. 13 Global Percutaneous nephrolithotomy market, 2013 - 2024 (USD Million)
FIG. 14 Global Other treatments market, 2013 - 2024 (USD Million)
FIG. 15 Urolithiasis management devices market end-use outlook key takeaways
FIG. 16 Urolithiasis management devices market: End-use movement analysis
FIG. 17 Global hospitals & clinics market, 2013 - 2024 (USD Million)
FIG. 18 Global ambulatory surgical centers market, 2013 - 2024 (USD Million)
FIG. 19 Regional market place: Key takeaways
FIG. 20 Regional outlook, 2015 & 2024
FIG. 21 Strategy framework
FIG. 22 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.